Serum β2-microglobulin (β2-m) levels were measured in oral carcinoma patients and compared with normal healthy controls. It was observed that there was a significant rise in serum β2- microglobulin in oral carcinoma patients. Progressively higher values were obtained as the cancer advanced clinically. Therefore the estimation of serum β2-microglobulin may be useful as one of a battery of tests in the assessment of oral carcinoma patients.
All Science Journal Classification (ASJC) codes
- Clinical Biochemistry